Raloxifene is an FDA-approved selective estrogen receptor modulator (SERM) that improves tissue quality by binding to collagen and increasing the bound water content in the bone matrix in a cell-independent manner. In this thesis, active tissue formation was induced by non-invasive external tibial loading in female mice and combined with raloxifene treatment to assess their combined effect on bone morphology and mechanical properties. Thermoregulation is an important factor that could have physiological consequences on research outcomes, and was introduced as an additional experimental factor in this study. We hypothesized that by removing the mild cold stress under which normal lab animals are housed, a metabolic boost would allow for furt...
Abstract Background Failure of surgical fixation in o...
Strain-induced adaption of bone has been well-studied in an axial loading model of the mouse tibia. ...
Raloxifene, a selective estrogen receptor modulator, is used for prevention and treatment of osteopo...
Raloxifene is an FDA-approved selective estrogen receptor modulator (SERM) that improves tissue qual...
Osteogenesis imperfecta (OI) is a genetic disease of Type I collagen and collagen-associated pathway...
Raloxifene (RAL) is an FDA-approved drug used to treat osteoporosis in postmenopausal women. RAL sup...
We have previously documented that raloxifene enhances the mechanical properties of dog vertebrae in...
Raloxifene, a selective estrogen receptor modulator (SERM), reduces fracture risk at least in part b...
Previous work has suggested that progression of experimental scoliotic curves in pinealectomized chi...
Bone Biology Laboratory http://www.iupui.edu/~bonelab/ Department of Anatomy and Cell Biology Indi...
Bisphosphonates represent the gold-standard pharmaceutical agent for reducing fracture risk. Long-te...
ABSTRACT Atypical antipsychotic (AA) drugs, such as risperidone, are associated with endocrine and m...
UNLABELLED: Room temperature housing (22 °C) results in premature cancellous bone loss in female mic...
<div><p>Abstract Raloxifene is an antiresorptive drug, selective estrogen receptor modulator (SERM) ...
Focal bone resorption (osteolysis) induced by wear particles contributes to long-term orthopedic joi...
Abstract Background Failure of surgical fixation in o...
Strain-induced adaption of bone has been well-studied in an axial loading model of the mouse tibia. ...
Raloxifene, a selective estrogen receptor modulator, is used for prevention and treatment of osteopo...
Raloxifene is an FDA-approved selective estrogen receptor modulator (SERM) that improves tissue qual...
Osteogenesis imperfecta (OI) is a genetic disease of Type I collagen and collagen-associated pathway...
Raloxifene (RAL) is an FDA-approved drug used to treat osteoporosis in postmenopausal women. RAL sup...
We have previously documented that raloxifene enhances the mechanical properties of dog vertebrae in...
Raloxifene, a selective estrogen receptor modulator (SERM), reduces fracture risk at least in part b...
Previous work has suggested that progression of experimental scoliotic curves in pinealectomized chi...
Bone Biology Laboratory http://www.iupui.edu/~bonelab/ Department of Anatomy and Cell Biology Indi...
Bisphosphonates represent the gold-standard pharmaceutical agent for reducing fracture risk. Long-te...
ABSTRACT Atypical antipsychotic (AA) drugs, such as risperidone, are associated with endocrine and m...
UNLABELLED: Room temperature housing (22 °C) results in premature cancellous bone loss in female mic...
<div><p>Abstract Raloxifene is an antiresorptive drug, selective estrogen receptor modulator (SERM) ...
Focal bone resorption (osteolysis) induced by wear particles contributes to long-term orthopedic joi...
Abstract Background Failure of surgical fixation in o...
Strain-induced adaption of bone has been well-studied in an axial loading model of the mouse tibia. ...
Raloxifene, a selective estrogen receptor modulator, is used for prevention and treatment of osteopo...